Journal of Cancer Therapy

Journal of Cancer Therapy

ISSN Print: 2151-1934
ISSN Online: 2151-1942
www.scirp.org/journal/jct
E-mail: jct@scirp.org
Citations    
"The MMTV-PyVT Transgenic Mouse as a Multistage Model for Mammary Carcinoma and the Efficacy of Antineoplastic Treatment"
written by Stephanie Shishido, Adélaïde Delahaye, Amanda Beck, Thu Annelise Nguyen,
published by Journal of Cancer Therapy, Vol.4 No.7, 2013
has been cited by the following article(s):
  • Google Scholar
  • CrossRef
[1] Effect of 2‐methoxyestradiol on mammary tumor initiation and progression
Cancer …, 2024
[2] Exploring the one health paradigm in male breast cancer
Yng Tay, G Cowan, S Chatterji, G Conti… - Journal of Mammary …, 2024
[3] Effect of 2‐methoxyestradiol treatment on early‐and late‐stage breast cancer progression in a mouse model
Cell Biochemistry …, 2023
[4] Characterization of Mammary Tumors Arising from MMTV-PyVT Transgenic Mice
Current Issues in …, 2023
[5] Sexual Dimorphism of Skeletal Muscle in a Mouse Model of Breast Cancer: A Functional and Molecular Analysis
International Journal of …, 2023
[6] An enhanced chemopreventive effect of methyl donor S-adenosylmethionine in combination with 25-hydroxyvitamin D in blocking mammary tumor growth and …
2020
[7] ROLE OF TET2 IN LUMINAL DIFFERENTIATION AND HORMONE THERAPY RESPONSE IN BREAST CANCER
2019
[8] 金花茶提取物对 MMTV-PyMT 转基因小鼠自发乳腺癌的预防作用研究.
Progress in Modern …, 2017
[9] CEP55 慢病毒表达载体构建和 U251-CEP55 细胞株的建立.
Progress in Modern …, 2017
[10] Neutrophils drive accelerated tumor progression in the collagen-dense mammary tumor microenvironment
2016
[11] Role of n-3 polyunsaturated fatty acids and exercise in breast cancer prevention: identifying common targets
Nutrition and metabolic insights, 2016
[12] Induction of apoptosis by PQ1, a gap junction enhancer that upregulates connexin 43 and activates the MAPK signaling pathway in mammary carcinoma cells
International Journal of Molecular Sciences, 2016
Free SCIRP Newsletters
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top